Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo-Theravance Lung Drug Gains Backing of FDA Advisers
Glaxo-Theravance Lung Drug Gains Backing of FDA Advisers
Glaxo-Theravance Lung Drug Gains Backing of FDA Advisers
Submitted by
admin
on April 17, 2013 - 4:34pm
Source:
Bloomberg
News Tags:
GSK
Breo Ellipta
FDA
COPD
Theravance
Headline:
Glaxo-Theravance Lung Drug Gains Backing of FDA Advisers
Do Not Allow Advertisers to Use My Personal information
